Generally, our study comprehensively analyzed the multiplatform data of TCGA to compare the biologic characteristics, intrinsic heterogeneities, and clinical features of the KEAP1/NFE2L2/CUL3 mutant and wild lung adenocarcinoma patients. This evidence concerns the gene NFE2L2 and lung adenocarcinoma.